Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

Geneva, CHE
Rue de Jargonnant 2
Geneva, CH-1207, CHE

Funding

TOTAL $23.5M
FUNDING TOTAL $23.5M
Series A, 10/2010
Index Ventures
€10M
Series A, 1/2011
Index Ventures
$2M
Series B, 9/2013
Index Ventures
LRM
€6M

Tags

Mind-NRG

Mind-NRG (www.mind-nrg.com), a Switzerland-based company focused on the development of a peptidic neurotrophic factor (NRG-101) with disease modifying potential that crosses the blood-brain barrier by a receptor-mediated transport to reach its target.

Recent Milestones

  • Dollar
    Mind-NRG received $7.72M (€6M) in Series B funding. (9/4/13)
    Posted 9/4/13 at 2:13am via bioportfolio.com
  • Dollar
    Mind-NRG received $2M in Series A funding. (1/11/11)
    Posted 1/12/11 at 5:17am via onbiovc.com
  • Dollar
    Mind-NRG received $13.8M (€10M) in Series A funding. (10/27/10)
    Posted 10/27/10 at 6:08pm via finsmes.com

Videos

Screenshots

Mind-NRG screenshot
Above: Mind-NRG
Uploaded: 1/12/11

Sources

  1. Mind-NRG Secures Funding from Index Ventures (finsmes.com) [edit]
  2. Mind-NRG, SA: Series A $2M (onbiovc.com) [edit]
  3. Mind-NRG Successfully Completes 6 Million Euro (~8 Million USD) Series B Financing. (bioportfolio.com) [edit]
Edit This Page
Last Edited 11/25/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy